Profile
Kelsey Tsai is a Vice President for Sandbox Healthcare.
She supports the Blue Venture Fund’s investments in Thrive (now Exact Sciences), Onc.AI, Sempre Health, AbleTo and Workit Health.
Prior to Sandbox, Kelsey was an MBA associate at ARCH Venture Partners, as well as an Innovation Fund associate for the University of Chicago’s seed stage tech and life sciences fund.
Kelsey started her career as a biotech equity research analyst at Morningstar.
Kelsey holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from Georgetown University.
She is also a CFA charterholder.
Kelsey Tsai active positions
| Companies | Position | Start |
|---|---|---|
213 Management LLC
 213 Management LLC Investment ManagersFinance 213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 2021-09-30 |
Training of Kelsey Tsai
| The University of Chicago Booth School of Business | Masters Business Admin |
| Georgetown University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
213 Management LLC
213 Management LLC Investment ManagersFinance 213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois. | Finance |
- Stock Market
- Insiders
- Kelsey Tsai
